Marshall Wace
MTEM

Marshall Wace’s Molecular Templates, Inc. MTEM Stock Holding History

Marshall Wace’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,566
Closed -$224K – 1972
2019
Q1 		$224K Buy
2,566
+928
+57% +$68K ﹤0.01% 1315
2018
Q4 		$99K Buy
+1,638
New +$114K ﹤0.01% 1373

Other funds holding MTEM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace's MTEM Position: Q2 2019 in Review

Marshall Wace sold out of Molecular Templates, Inc. (MTEM) in Q2 2019, closing a stake of 2,566 shares — an estimated $224K sold.

Marshall Wace first reported a position in MTEM in Q4 2018 and held it in 2 quarters. The position peaked at $224K in Q1 2019. 71 funds tracked by Wall St. Rank hold MTEM as of Q2 2019.

  • Marshall Wace reported no remaining Molecular Templates, Inc. position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace sold 2,566 Molecular Templates, Inc. shares in Q2 2019, an estimated $224K.
  • Marshall Wace first reported a position in Molecular Templates, Inc. in Q4 2018 and held it in 2 quarters.
  • Marshall Wace's Molecular Templates, Inc. position peaked at $224K in Q1 2019.
  • 71 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2019.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.